Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-23

Clinical Trial Update: Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation [NA]

View source ↗

Summary

A clinical study is evaluating InnovHeart's SATURN Trans-Septal Transcatheter Mitral Valve Replacement System to reduce severe symptomatic mitral regurgitation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SATURN Trans-Septal Transcatheter Mitral Valve Replacement System

Snippet

Sponsor: InnovHeart | Conditions: Heart Failure | NA | Status: RECRUITING